Anxiety, Nausea
Conditions
Brief summary
The purpose of this research study is to determine whether using aromatherapy during chemotherapy infusion treatments in the outpatient Oncology setting promote relief of nausea and anxiety. The objectives of this study are: 1. To promote relief of nausea using peppermint aromatherapy oil in an outpatient oncology setting. 2. To promote relief of anxiety using lavender aromatherapy oil in an outpatient oncology setting.
Detailed description
Subject Selection: Every outpatient oncology patient experiencing nausea and/or anxiety during an infusion visit will be offered hospital-approved aromatherapy of Peppermint oil or Lavender oil. If patient says yes, then they will be selected for the study and infusion nurse will notify the study co-investigators or principal investigator. Informed consent will then be obtained by co-investigators or principal investigator of the study. The consents as well as the data collection tool sheets will be numbered without identifying patient's personal information. Peppermint oil aromatherapy and/or lavender oil aromatherapy will then be administered to consented patients. Method of Subject Identification and Recruitment: Every outpatient oncology patient experiencing nausea and/or anxiety during an infusion visit will be offered hospital- approved aromatherapy of Peppermint oil or Lavender oil. If patient says yes, then they will be selected for the study and infusion nurse will notify the study co-investigators or principal investigator. Informed consent will then be obtained by co-investigators or principal investigator of the study. The consents as well as the data collection tool sheets will be numbered without identifying patient's personal information. Peppermint oil aromatherapy and/or lavender oil aromatherapy will then be administered to consented patients.
Interventions
OTHERYoung Living Lavender Essential Oil
For qualified patients one to two drops of hospital approved essential oil will be placed on a 4X4 gauze and will be offered to the patient during their infusion visit. This gauze will be placed in a sealable clear plastic bag and the patient will be instructed to use one sniff at a time.
Sponsors
Central DuPage Hospital
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* All outpatient Oncology patients \> 18 years of age * Non pregnant * Not cognitively impaired * English speaking only * Patients who report nausea and/or anxiety
Exclusion criteria
* All outpatient oncology patients \<18 years of age * Pregnant * Cognitively impaired * Non-English Speaking * Patients who do not report nausea and/or anxiety * Patients with a known allergy to peppermint and/or lavender aromatherapy oil
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Post Intervention Interview From | Immediately upon Completion of the patient's infusion | After the patients' infusion they will be asked questions from this form |
Countries
United States
Contacts
PRINCIPAL_INVESTIGATORLorraine Mack, MSN
Central DuPage Hospital
Outcome results
None listed